Angiodynamics up after annual sales forecast raise

Shares of medical device maker Angiodynamics ANGO.O rise about 8% to $14.28 in premarket trading

Co lifts FY2026 net sales forecast in the range of $312 million to $314 million from prior expectations of $308 million to $313 million

Also raises annual adjusted EBITDA between $8 million to $10 million, compared with a previous range of $6 million to $10 million

Co reports Q2 net loss of $6.4 million vs net loss of $10.7 million last year

Jim Clemmer will retire as president and CEO during FY2027 once the company appoints a successor

ANGO stock up ~40% in 2025